Facebook Linkedin RSS Twitter Youtube
Home 2024

Rare diseases

Neurodegeneration Due to Ultra-Rare Disease Slowed by AAV Gene Therapy
Drug Discovery

Neurodegeneration Due to Ultra-Rare Disease Slowed by AAV Gene Therapy

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
GEN Edge

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

Symptoms in Rare Genetic Syndrome Alleviated by Repurposed Autoimmune Disease Drug
Drug Discovery

Symptoms in Rare Genetic Syndrome Alleviated by Repurposed Autoimmune Disease Drug

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster
Drug Discovery

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster

Democratizing Precision Medicine
Cancer

Democratizing Precision Medicine

Bye, Bye, Baltimore: GEN’s Takeaways from ASGCT
Genome Editing

Bye, Bye, Baltimore: GEN’s Takeaways from ASGCT

FDA Clears Prime Medicine’s IND for First Prime Editing Therapy
Genome Editing

FDA Clears Prime Medicine’s IND for First Prime Editing Therapy

StockWatch: Biogen Q1 Results Beat Expectations, for a Change
Drug Discovery

StockWatch: Biogen Q1 Results Beat Expectations, for a Change

2025 Cell & Gene Therapy Reimbursement Outlook
Bioprocessing

2025 Cell & Gene Therapy Reimbursement Outlook

U.K. Innovation Hubs for Gene Therapies Now Open
Bioprocessing

U.K. Innovation Hubs for Gene Therapies Now Open

123...40Page 1 of 40

Recently Featured

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.